UAE Dialysis Market Analysis Report 2022 to 2030

UAE Dialysis Market Analysis

$ 3999

The UAE Dialysis Market is projected to grow from $0.581 Bn in 2022 to $1.036 Bn by 2030, registering a CAGR of 7.5% during the forecast period of 2022-2030. The increasing awareness about the importance of kidney health and the availability of treatments is also expected to drive the growth of the dialysis market in the UAE. Fresenius Medical Care is one of the leading providers of dialysis products and services in the UAE, with a significant presence in the market.

ID: IN10AEPH010 CATEGORY: Pharmaceuticals GEOGRAPHY: UAE AUTHOR: Shivam Zalke

Buy Now

UAE Dialysis Market Executive Summary

The UAE Dialysis Market is projected to grow from $0.581 Bn in 2022 to $1.036 Bn by 2030, registering a CAGR of 7.5% during the forecast period of 2022-30.

The dialysis market in the United Arab Emirates (UAE) is expected to grow significantly in the coming years due to the increasing incidence of chronic kidney disease and the growing aging population in the country. The UAE's healthcare sector is rapidly expanding, with the government investing heavily in the development of new hospitals and clinics.

The market is majorly dominated by companies such as Fresenius Medical Care, DaVita, and Nipro Medical Corporation.

The UAE government has also implemented various policies to improve access to dialysis treatment for patients with kidney disease. These policies include the inclusion of dialysis treatment under the basic benefits package of the country's mandatory health insurance scheme and the establishment of specialized kidney disease centers.

In addition, private healthcare providers also play an important role in the dialysis market in the UAE. Many of the private hospitals and clinics in the country offer dialysis treatment, and the growing number of expatriates in the country is expected to boost the demand for private dialysis services.

In summary, the UAE dialysis market is expected to grow due to the increasing incidence of chronic kidney disease, a growing aging population, and government support through policies and investments in healthcare infrastructure.

uae dialysis market analysis

Market Dynamics

Market Drivers

The key drivers of the UAE dialysis market include:

Increasing incidence of chronic kidney disease: The prevalence of chronic kidney disease is on the rise in the UAE, due to factors such as diabetes, hypertension, and obesity. This increase in the number of patients with kidney disease is driving the growth of the dialysis market in the country.
Growing aging population: The aging population in the UAE is also a key driver of the dialysis market. As the population ages, the incidence of chronic kidney disease increases, leading to an increased demand for dialysis treatment
Government support: The UAE government has implemented various policies to improve access to dialysis treatment for patients with kidney disease, such as including dialysis treatment under the basic benefits package of the country's mandatory health insurance scheme and establishing specialized kidney disease centers
Private healthcare providers: Private healthcare providers also play an important role in the dialysis market in the UAE. Many of the private hospitals and clinics in the country offer dialysis treatment, and the growing number of expatriates in the country is expected to boost the demand for private dialysis services.
Technological Advancements: The advent of new technologies such as home dialysis, peritoneal dialysis, and nocturnal hemodialysis are expected to drive market growth in the coming years
Increasing awareness about kidney diseases: The increasing awareness about the importance of kidney health and the availability of treatments is also expected to drive the growth of the dialysis market in the UAE

Competitive Landscape

Key Players

Some key players in the UAE dialysis market include:

Fresenius Medical Care: One of the leading providers of dialysis products and services in the UAE, with a significant presence in the market
DaVita: Another major player in the UAE dialysis market, providing dialysis treatment and related services to patients in the country
Nipro Medical Corporation: A Japan-based company that is one of the leading providers of dialysis products and services in the UAE
B. Braun Melsungen AG: German-based company that provides dialysis products and services in the UAE
NxStage Medical: American-based company that provides dialysis products and services in the UAE
Medtronic: American-based company that provides dialysis products and services in the UAE
JMS Group: Japan-based company that provides dialysis products and services in the UAE
Asahi Kasei Medical: Japan-based company that provides dialysis products and services in the UAE
Nikkiso: Japan-based company that provides dialysis products and services in the UAE
Gambro: Sweden-based company that provides dialysis products and services in the UAE

Healthcare Policies and Regulatory Landscape

In the United Arab Emirates (UAE), the dialysis market is primarily regulated by the Ministry of Health and Prevention (MOHAP), which is responsible for the oversight and regulation of the healthcare sector in the country.

The UAE government has implemented various policies to improve access to dialysis treatment for patients with kidney disease. One of the key policies is the inclusion of dialysis treatment under the basic benefits package of the country's mandatory health insurance scheme, which is known as the Abu Dhabi Basic Plan and Dubai Basic Plan. This ensures that all residents in the country have access to dialysis treatment regardless of their ability to pay.

Additionally, the government has also established specialized kidney diseases centers such as the Sheikh Khalifa Medical City and Tawam Hospital, which provide dialysis treatment to patients with kidney disease.

The Ministry of Health and Prevention (MOHAP) also plays a role in setting guidelines and standards for the treatment of kidney disease in the UAE. These guidelines include the setting of standards for the operation of dialysis centers, the provision of dialysis equipment and supplies, and the training of healthcare professionals in the field of nephrology.

In terms of reimbursement policies, the government typically covers the costs of dialysis for patients with chronic kidney disease, but there may be some out-of-pocket costs for patients depending on their specific coverage. Dialysis centers in the UAE are expected to follow the guidelines and regulations established by the Ministry of Health and Prevention (MOHAP)

Overall, the government policies and healthcare regulations in the UAE ensure that dialysis treatment is widely accessible and affordable for patients with kidney disease, and the specialized kidney disease centers and mandatory health insurance schemes play a key role in this.

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Dialysis Market Segmentation

The Dialysis Market is segmented as mentioned below:

By Type (Revenue, USD Billion):

Hemodialysis (HD)
- Conventional Hemodialysis
- Short daily hemodialysis
- Nocturnal hemodialysis
Peritoneal dialysis (PD)
- Continuous Ambulatory Peritoneal Dialysis (CAPD)
- Automated Peritoneal Dialysis (APD)

By Product & Services (Revenue, USD Billion):

Equipment
- Dialysis Machines
- Water Treatment Systems
- Others Dialysis Equipment
Consumables
- Dialyzers
- Catheters
- Other Dialysis Consumables
Dialysis Drugs
Services

By End User (Revenue, USD Billion):

In-center dialysis
Home dialysis

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.